Get started
Author

Aya Nakaya

Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab
2018 · Aya Nakaya, Takayasu Kurata, et al. · International Journal of Clinical Oncology · 133
PDF
The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity
2010 · Aya Nakaya, Morihiko Sagawa, et al. · Leukemia Research · 96
Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer
2018 · Maiko Niki, Aya Nakaya, et al. · Oncotarget · 77
PDF
Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?
2016 · Aya Nakaya, Shinya Fujita, et al. · Leukemia Research · 51
Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplantation Outcomes? A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy
2014 · Aya Nakaya, Takehiko Mori, et al. · Transplantation and Cellular Therapy · 45
PDF
Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent Era
2017 · Aya Nakaya, Shinya Fujita, et al. · Hematology Reports · 42
PDF
Retrospective analysis of bevacizumab‐induced hypertension and clinical outcome in patients with colorectal cancer and lung cancer
2016 · Aya Nakaya, Takayasu Kurata, et al. · Cancer Medicine · 37
PDF
Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation
2017 · Shosaku Nomura, Kazuyoshi Ishii, et al. · Transplant Immunology · 33
PDF
Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report
2018 · Maiko Niki, Aya Nakaya, et al. · Molecular and Clinical Oncology · 26
PDF
Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
2017 · Yutaka Tsukune, Makoto Sasaki, et al. · Blood Cancer Journal · 24
PDF
Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphoma
2019 · Yoshiko Azuma, Aya Nakaya, et al. · Leukemia Research Reports · 22
PDF
Successful Treatment of Adult Onset Langerhans Cell Histiocytosis with Multi-Drug Combination Therapy
2011 · Eri Matsuki, Yuiko Tsukada, et al. · Internal Medicine · 21
PDF
Efficacy and safety of anagrelide as a first‐line drug in cytoreductive treatment‐naïve essential thrombocythemia patients in a real‐world setting
2019 · Tomoki Ito, Yoshinori Hashimoto, et al. · European Journal Of Haematology · 20
PDF
A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study
2015 · Kimihiro Matsumoto, Nobuyuki Takayama, et al. · International Journal of Hematology · 19
Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T‐cell leukemia/lymphoma: A retrospective analysis
2020 · Atsushi Satake, Akiko Konishi, et al. · European Journal Of Haematology · 16
Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis
2022 · Yoshiyuki Onda, Junya Kanda, et al. · Therapeutic Advances in Hematology · 15
PDF
Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum
2018 · Kansai Myeloma Forum Investigators, Yayoi Matsumura-Kimoto, et al. · International Journal of Hematology · 15
Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphoma
2016 · Aya Nakaya, Shinya Fujita, et al. · Leukemia Research Reports · 15
PDF
Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model: “Radioimmunotherapy to Overcome Transfusion-Induced Sensitization”
2021 · Aya Nakaya, Huiying Qiu, et al. · Transplantation and Cellular Therapy · 14
Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma
2018 · Shosaku Nomura, Tomoki Ito, et al. · Journal of Blood Medicine · 14
PDF
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis
2021 · Teruhito Takakuwa, Ryosuke Yamamura, et al. · European Journal Of Haematology · 13
Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry
2020 · Aya Nakaya, Takae Kohara, et al. · International Journal of Hematology · 13
Evaluation of eltrombopag in patients with aplastic anemia in real-world experience
2019 · Akiko Konishi, Aya Nakaya, et al. · Leukemia Research Reports · 11
PDF
Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study
2018 · Tomoki Ito, Akiko Konishi, et al. · Frontiers in Nutrition · 11
PDF
Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World Experience
2017 · Aya Nakaya, Shinya Fujita, et al. · Acta Haematologica · 10
Works count: 104
Citation count: 961
H-index: 15
I10-index: 25
Year
Topic
Type